Food and Drug Administration
Agency of the United States Department of Health and Human Services
Food and Drug Administration ▸ Facts ▸ Comments ▸ News ▸ Videos
Gilead's remdesivir gets U.S. FDA approval
Credit: Reuters Studio Duration: 01:29Published
California to review any COVID-19 vaccine
Credit: Reuters - Politics Duration: 01:25Published
Twitter blocks post by top Trump pandemic adviser
Credit: Reuters - Politics Duration: 02:09Published
FDA faults quality control at Eli Lilly plant
Credit: Reuters Studio Duration: 01:36Published
U.S. seeing 'clearly a resurgence' of coronavirus
Credit: Reuters - Politics Duration: 01:33Published
FDA updates guidelines on coronavirus vaccine
Credit: ABC Action News Duration: 01:27Published
FDA, EU diverge on AstraZeneca COVID-19 vaccine
Credit: Reuters Studio Duration: 01:42Published
J&J launches final study of COVID-19 vaccine
Credit: Reuters - Politics Duration: 01:09Published
Visby's COVID-19 test gets FDA approval
Credit: Reuters Studio Duration: 02:22Published
PM 'virtue signalling' with civil servants return call
Credit: ODN Duration: 01:23Published
PM ‘virtue signalling’ with civil servants return call
Credit: ODN Duration: 01:23Published
McEnany: No one pressuring FDA to approve vaccine
Credit: Reuters Studio Duration: 01:37Published
U.S. coronavirus cases top 6 million
Credit: Reuters - Politics Duration: 01:43Published
New Acne Cream Targets Hormones
Credit: Wochit News Duration: 00:34Published
S&P 500 Closes At Record High
Credit: Wochit News Duration: 00:37Published
You Might Like
This week on "Face the Nation," October 25, 2020National Security Adviser Robert O'Brien, and FDA Commissioner Scott Gottlieb appear on Sunday's "Face the Nation"
FDA approves remdesivir as COVID-19 treatmentThe Food and Drug Administration approved the antiviral drug remdesivir to treat adults who are hospitalized with COVID-19, although it has not been proven to reduce deaths. Dr. Bob Lahita joins CBSN..
Also reported by •The Verge •USATODAY.com
Covid 19 coronavirus: FDA approves first drug: antiviral remdesivirUS regulators on Thursday approved the first drug to treat Covid-19: remdesivir, an antiviral medicine given to hospitalised patients through an IV.The drug, which California-based Gilead Sciences is..
F.D.A. Approves Remdesivir as First Drug to Treat Covid-19The move indicated that the drug had cleared more rigorous hurdles since it was given emergency authorization in May.
Also reported by •CBS News •The Verge
Health secretary denies report he wants to oust FDA headAccording to a report published in Politico, Azar had expressed his frustration with Hahn to several allies within his department
HHS Secretary Alex Azar on COVID-19 vaccine timeline and "concerning" pandemic trendCoronavirus cases are increasing in nearly 75% of the U.S., according to the Centers for Disease Control. Health and Human Services Secretary Alex Azar joined "CBS This Morning" to discuss the..
Pharmaceutical executives face prison time for racketeering, after breaking FDA laws, enticing doctors to boost opioid salesA former sales VP for a pharmaceutical company was sentenced to prison tells 60 Minutes he bribed doctors to prescribe fentanyl drugs. Bill Whitaker reports.
Did the FDA ignite the opioid epidemic?A drug manufacturer denounces his own industry and explains to 60 Minutes how a label change by the FDA expanded the use of opioids. Bill Whitaker reports.
Doctor weighs in on coronavirus vaccine timeline, surge in U.S. casesModerna's CEO says interim results are expected next month from a large clinical trial of the company's coronavirus vaccine -- one of several vaccines in the final phase of testing. If all goes well,..
US trial of AstraZeneca Covid vaccine may resume this week - ReportAstraZeneca Plc's COVID-19 vaccine trial in the United States is expected to resume as early as this week after the U.S. Food and Drug Administration completed its review of a serious illness in a..
Government agency will investigate Trump administration political influence over FDA, CDCBoth agencies have been caught in political crossfire since the start of the pandemic, as preventative health measures became politicized.
Gottlieb says "biggest wave" of coronavirus infections still to comeThe former FDA commissioner says the U.S. has "two or three very hard months ahead of us."
Transcript: Scott Gottlieb on "Face the Nation"The following is a transcript of an interview with former FDA Commissioner Scott Gottlieb that aired October 18, 2020, on "Face the Nation."
Don't inject politics into vaccine policyPeople are already suspicious about vaccines. Political pressure on the Food and Drug Administration will further undermine trust.
Rapid research in a deadly epidemic pays offImage: CDC This week’s US Food and Drug Administration approval of an Ebola drug is a big milestone in drug development — one that’s closely tied to our current efforts to fight..
Pfizer will not seek COVID-19 vaccine authorization before electionPfizer announced Friday it will apply for FDA emergency use authorization for its COVID-19 vaccine "soon after the safety milestone is achieved in the third week in November." Meg Oliver has details.
Pregnant women should not take ibuprofen after 20 weeks, FDA says. It could harm the baby's kidneys.Some of the most commonly used pain and fever medications could cause fetal kidney problem at or after 20 weeks of pregnancy, according to the FDA.
FDA approves first treatment for EbolaImage: CDC The Food and Drug Administration approved a drug tested during the 2018 Ebola epidemic as a treatment for the disease. It’s the first therapy approved by the agency for Ebola, and shows..
Johnson & Johnson pauses COVID-19 vaccine trial due to unexplained illnessIllustration by Ana Kova Johnson & Johnson’s clinical trial of its COVID-19 vaccine was paused after a volunteer came down with an unexplained illness. The company did not disclose what the..
Gottlieb predicts "a lot of death and disease" as COVID cases riseThe former FDA commissioner says the U.S. is "in a difficult situation heading into the fall" as the virus surges in parts of the country
What would be required to get Trump's new favorite COVID antibody treatment on the market?President Trump touts an experimental COVID antibody cocktail made by Regeneron and wants it free for all Americans. The FDA can fast-track approval.
Trump is promising free antibody treatments for everyone. It won’t be that simple.Coronavirus Trump is promising free antibody treatments for everyone. It won’t be that simple. The president is talking up the experimental therapies as the possibility of a coronavirus vaccine..
Why Apple needed the FDA to sign off on its EKG but not its blood oxygen monitorSensors on the Apple Watch Series 6 monitor heart rate and blood oxygen levels. During the announcement of the Apple Watch Series 6, the company heralded the newest element — a blood oxygen..
Doctor on FDA's COVID vaccine guidelines and VP debate safetyThe FDA has issued guidelines for coronavirus vaccine manufacturers which make it extremely unlikely that a vaccine will be approved before Election Day. And there's ongoing concern about the COVID-19..
A Dose of Vaccine RealityThe F.D.A. releases guidelines that had been trailed by politics: This is your morning tip sheet.
FDA's new vaccine guidance that pushes approval past electionPresident Trump said Monday that a vaccine is coming "momentarily," but the FDA says more safety monitoring comes first.
FDA coronavirus vaccine guidelines raise doubts over approval by Election DayGuidelines by the FDA all but close the door on having a coronavirus vaccine by Election Day. Meg Oliver reports.
CDC changes guidance on COVID-19, says airborne transmission is possibleThe CDC has again updated its COVID-19 transmission guidance, saying the virus can travel farther than six feet though "airborne" transmission. At the FDA, career scientists are reportedly being..
Coronavirus: White House blocks FDA's Covid vaccine guidelinesThe White House has blocked new Food and Drug Administration (FDA) guidelines on bringing potential vaccines for Covid-19 to market that would almost certainly have prevented their approval before the..
Also reported by •NYTimes.com
Gottlieb says those around Trump earlier in the week "not in the clear"The former FDA commissioner says "anyone who was with the president Tuesday, Wednesday is not in the clear."
Is a coronavirus vaccine possible in 2020?Pfizer says it could have results as soon as the end of October for its possible COVID vaccine. But health experts are concerned about avoiding any possible political interference in the process ahead..
Full transcript of "Face the Nation" on September 27, 2020On this "Face the Nation" broadcast, White House Chief of Staff Mark Meadows and Former FDA Commissioner Scott Gottlieb sat down with Margaret Brennan
Gottlieb warns of "very dangerous season" for coronavirus as cases riseThe former FDA commissioner says the number of infections remains high heading into the fall and winter.
TikTok "Benadryl Challenge" prompts FDA warning on overdosesAgency cites reports of teens hospitalized or dead from misuse of allergy medication in an attempt to get high.
Recalled mushrooms likely linked to salmonella outbreak shipped to restaurants in more than 30 statesThe FDA and CDC are investigating a multi-state outbreak of salmonella infections that has sickened 41 and is likely linked to wood ear mushrooms.
Trump says he may not OK stricter FDA standards for vaccine approvalMr. Trump told reporters tightened standards from the FDA for an emergency use authorization for a coronavirus vaccine "sounds like a political move."
Oxford Covid vaccine: AstraZeneca still waiting for FDA nod to resume US trialAstraZeneca is still waiting for the U.S. drug regulator to approve the restart of the clinical trial of its potential COVID-19 vaccine in the United States almost three weeks after it was paused due..
Covid-19 News: Live UpdatesPresident Trump said the White House “may or may not” approve new F.D.A. guidelines that would toughen the process for approving a coronavirus vaccine.
Trump May Reject Tougher F.D.A. Vaccine Standards, Calling Them ‘Political’In suggesting he might reject tougher guidelines, President Trump once again undermined efforts by government scientists to bolster public confidence in their work.